FDA CommissionerOvjeren akaunt

@FDACommissioner

This is an archived account. The account was previously used by Acting FDA Commissioners. Follow to keep up with the 24th FDA Commissioner.

Vrijeme pridruživanja: travanj 2019.

Tweetovi

Blokirali ste korisnika/cu @FDACommissioner

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FDACommissioner

  1. ==== NOTE FROM : Tweets prior to this point are from previous federal officials. ====

    Poništi
  2. As I return to my full-time position at HHS as , I leave with a greater appreciation for FDA’s mission and look forward to continuing our collaboration in the advancement of public health. – Adm. Brett P. Giroir

    Prikaži ovu nit
    Poništi
  3. It’s been my privilege to serve alongside the dedicated staff of the as Acting Commissioner. It is with great enthusiasm that I hand the reins over to Dr. Stephen Hahn as the 24th FDA Commissioner.

    Prikaži ovu nit
    Poništi
  4. We issued a draft guidance addressing implementation of these amendments, which we anticipate will facilitate early pediatric assessment of certain targeted cancer drugs and accelerate the development of new, safe and effective therapies for pediatric patients

    Prikaži ovu nit
    Poništi
  5. Thanks to amendments to the Federal Food, Drug, and Cosmetic Act made by the FDA Reauthorization Act of 2017, we have a new mechanism to require the evaluation of certain novel cancer medicines for potential pediatric treatment

    Prikaži ovu nit
    Poništi
  6. When it comes to medical product innovation, children must always remain front-of-mind, particularly those with dire needs

    Prikaži ovu nit
    Poništi
  7. It has been an honor and a privilege to be part of the FDA team these past weeks. FDA staff are dedicated & passionate about protecting and promoting public health and I have enjoyed working with & learning from the staff.

    Prikaži ovu nit
    Poništi
  8. I am pleased to announce that Dr. Stephen M. Hahn has been confirmed as 24th Commissioner of Food & Drugs. As an experienced physician, published researcher & health care leader, I know he will successfully lead FDA in its critical task of protecting & promoting public health.

    Prikaži ovu nit
    Poništi
  9. Strong community partnerships are important as we work on “Ending the HIV/AIDS Epidemic: Community by Community.” Today, , we remember those we lost, and we renew our commitment to . More here in my blog post:

    Poništi
  10. Together with improved provider education, patient empowerment, and improved care delivery systems, these newly approved drugs have the potential to immediately impact people living with .

    Prikaži ovu nit
    Poništi
  11. We remain committed to raising the profile of this disease as a public health priority and to approving new therapies that are proven to be safe and effective.

    Prikaži ovu nit
    Poništi
  12. Today, we approved a novel treatment to target the central abnormality in disease giving additional hope to those who live with this debilitating blood disorder

    Prikaži ovu nit
    Poništi
  13. All FDA-approved biosimilar & interchangeable insulin products will meet robust scientific standards. Patients & healthcare providers will be able to rely on their safety & effectiveness, just like their reference products.

    Prikaži ovu nit
    Poništi
  14. Today’s draft guidance is intended to help facilitate product development of biosimilar and interchangeable insulin products by clarifying what data and information may be necessary.

    Prikaži ovu nit
    Poništi
  15. The high cost of insulin raises serious concerns about the ability of many patients with diabetes to access insulin products. Today’s draft guidance reinforces our commitment to facilitating development of and improving patient access to insulin products.

    Prikaži ovu nit
    Poništi
  16. Hope has never been higher for people living with this painful and deadly blood disorder – and for their families and supporters – with a pipeline of new treatments on the horizon like the one we approved today.

    Prikaži ovu nit
    Poništi
  17. Today, we approved the first targeted therapy to treat patients with a painful complication disease.

    Prikaži ovu nit
    Poništi
  18. One of the critical ways can work to curb the disturbing e-cigarette trend is by continuing to educate youth, parents & teachers about the dangers of e-cig use. Educating students has been & will continue to be an important component of FDA's Youth Tobacco Prevention Plan

    Prikaži ovu nit
    Poništi
  19. Today, announced an expansion of its collaboration with to develop & distribute educational resources to both middle & high school educators across the U.S. to reach even more youth who have tried or are considering trying e-cigarettes.

    Prikaži ovu nit
    Poništi
  20. ==== NOTE FROM : Tweets prior to 11/2/2019 are from previous federal officials. ====

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·